 Predictive Oncology Inc. NASDAQ:POAI said it has closed two concurrent offerings with several institutional investors, raising gross proceeds of approximately 7.2 million before placement agent fees and other offerings expenses. The company intends to use the net proceeds from the offerings for working capital purposes. 